Tempest Therapeutics Inc (TPST) - Total Liabilities

Latest as of March 2026: $9.93 Million USD

Based on the latest financial reports, Tempest Therapeutics Inc (TPST) has total liabilities worth $9.93 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore TPST net asset momentum to track the company's year-over-year net asset growth rate.

Tempest Therapeutics Inc - Total Liabilities Trend (2011–2025)

This chart illustrates how Tempest Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. See Tempest Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Tempest Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Tempest Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Draper Esprit PLC LSE:GROW	UK	GBX157.20 Million
Japan Vietnam Medical Instrument JSC VN:JVC	Vietnam	₫145.74 Billion
TalkPool AG ST:TALK	Sweden	Skr4.46 Million
NSN Co. Ltd KQ:031860	Korea	₩20.47 Billion
Kainos Group PLC LSE:KNOS	UK	GBX164.47 Million
Kier Group PLC LSE:KIE	UK	GBX3.04 Billion
Akdeniz Yatirim Holding AS IS:AKYHO	Turkey	TL112.52 Million
Nukkleus Inc NASDAQ:NUKK	USA	$43.71 Million

Liability Composition Analysis (2011–2025)

This chart breaks down Tempest Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tempest Therapeutics Inc (TPST) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.74	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	12.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.92	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tempest Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tempest Therapeutics Inc (2011–2025)

The table below shows the annual total liabilities of Tempest Therapeutics Inc from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	$10.26 Million	-54.11%
2024-12-31	$22.36 Million	-9.96%
2023-12-31	$24.84 Million	-11.23%
2022-12-31	$27.98 Million	-24.63%
2021-12-31	$37.12 Million	-59.50%
2020-12-31	$91.66 Million	+507.03%
2019-12-31	$15.10 Million	+37.87%
2018-12-31	$10.95 Million	+126.80%
2017-12-31	$4.83 Million	-66.29%
2016-12-31	$14.32 Million	+21.78%
2015-12-31	$11.76 Million	+14.79%
2014-12-31	$10.25 Million	+75.34%
2013-12-31	$5.84 Million	+179.22%
2012-12-31	$2.09 Million	+174.67%
2011-12-31	$762.00K	--

About Tempest Therapeutics Inc

NASDAQ:TPST USA Biotechnology

Market Cap

$12.68 Million

Market Cap Rank

#26406 Global

#5439 in USA

Share Price

$0.86

Change (1 day)

-0.86%

52-Week Range

$0.86 - $11.83

All Time High

$3314.25